ReviewMicroorganisms2026
Emerging and Underdetected Colonization Factors in Enterotoxigenic
Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Adhesionto the gut epithelium is the first step in ETEC infection and is mediated by colonization factors (CFs). CFs are also the main targets of the ETEC vaccines currently in development, which are based on a small set of CFs considered to be the most prevalent. However, a large proportion of clinical isolates are reported as CF-negative when screened with standard PCR panels. This is partly because ETEC adhesins are more diverse than previously appreciated, and partly because the methods used to detect them only screen for a small, historically defined set of CFs. These two explanations are difficult to separate, and both suggest that CF diversity, and with it the coverage of current CF-based vaccines, has likely been underestimated. This review examines emerging and underdetected CFs in human ETEC, focusing on κ- and γ-clade adhesins such as CS23 and their links to animal-associated fimbriae. It discusses the implications of this growing diversity for vaccine development, the need for continued surveillance as the CF landscape evolves, and approaches to achieving broader vaccine coverage across the expanding diversity of ETEC adhesins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.